Lamisil Uno (Terbinafine)

Terbinafine belongs to the allylamine class of antifungals. It blocks the fungal enzyme squalene epoxidase, which is required for synthesising ergosterol, a key component of fungal cell membranes. The resulting buildup of squalene and loss of ergosterol disrupts membrane integrity, leading to fungal cell death.

The specific dosing regimen for Lamisil Uno is determined by the prescribing clinician based on the infection type, severity, patient age and skin condition. Typically, a thin layer is applied to the clean, dry affected area once or twice daily for the period recommended by the healthcare professional.

Safety data for topical terbinafine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil Uno.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Compared with azole antifungals, terbinafine has a different mechanism targeting squalene epoxidase, which can result in faster fungal clearance for dermatophyte infections. It is often preferred for its once‑ or twice‑daily dosing and lower potential for drug‑enzyme interactions, though choice of therapy should be individualized by a clinician.

Store Lamisil Uno at room temperature, ideally below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children. Do not freeze or expose the product to extreme temperatures.

Before application, wash and thoroughly dry the affected skin area. Apply a thin layer of the cream or gel to the lesion and a small margin of surrounding healthy skin. Rub gently until the product is absorbed. Follow the frequency and duration prescribed by your healthcare professional.

Although rare, serious adverse reactions can include severe allergic responses such as facial swelling, difficulty breathing, or widespread rash. Systemic absorption may rarely cause liver enzyme abnormalities. Patients should seek immediate medical attention if they experience signs of a serious allergic reaction or unexplained systemic symptoms.

Lamisil Uno should be avoided by individuals with a known hypersensitivity to terbinafine, its excipients, or any allylamine antifungal. It is also contraindicated on severely damaged, inflamed or infected skin not related to a fungal infection, and should be used with caution in patients with pre‑existing liver disease.